Previous 10 | Next 10 |
InMode (NASDAQ: INMD ) : Q2 Non-GAAP EPS of $0.24 beats by $0.03 ; GAAP EPS of $0.21. More news on: InMode Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...
YOKNEAM, Israel, Aug. 5, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its second quarter ended June 30, 2020 . Second Quarter 2020 Highli...
YOKNEAM, Israel , Aug. 3, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy , Chairman and Chief Executive Officer, Dr. Michael Kreindel , co-founder and Chief Technology Officer, Yair ...
LAKE FOREST, Calif. , July 27, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is thrilled to announce it has been honored with multiple beauty award wins in national publications for its non-invasive hands-fre...
InMode 's (NASDAQ: INMD) shares are skyrocketing 13.7% higher at 3:25 p.m. EDT on Monday after management announced its second-quarter 2020 revenue would likely be between $30.2 million and $30.6 million, which is significantly higher than analysts' outlook for $16.9 million. The company also...
InMode ( INMD +11.7% ) expects Q2 revenues in the range of $30.2M - $30.6M vs. consensus of $16.9M and non-GAAP diluted EPS in the range of $0.20 - $0.22 vs. consensus of -$0.09. More news on: InMode Ltd., Healthcare stocks news, Stocks on the move, , Read more ...
YOKNEAM, Israel, July 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it will release its financial results for the second quarter 2020 before the Nasdaq market opens on Wednesday, August 5, 2...
Israel-based InMode ( INMD ) is a leading global provider of minimally and non-invasive cosmetic procedures. The company develops, manufactures and markets devices harnessing novel radio-frequency technology, explains Tom Bishop , editor of BI Research . Most notably InM...
YOQNEAM, Israel , July 6, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce that it has received clearance from the China National Medical Products Administration NMPA - (previously known a...
Introduction Through Week 26 of 2020, the Premium Portfolio has gained +14.43%, substantially leading the S&P 500 benchmark by +21.29%. These returns were achieved by actively trading in 11 fewer weeks (nearly halted for an entire quarter) using the alerts of the Momentum Gauge™ t...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...